Inflammatory disorders

FDA approves Wezlana for multiple inflammatory diseases

The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.

Oncology & Cancer

Preventing collateral damage in cancer treatment

Using a simple concept and a patented Sandia sensor that detects radioactive materials, a team at Sandia National Laboratories has developed a patch to stop damage to healthy tissue during proton radiotherapy, one of the ...

Genetics

Novel cause of brain mosaicism and focal epilepsy identified

In most people, every cell in their body contains the same genetic information. However, sometimes people can have two or more genetically different sets of cells. This usually happens during fetal development and is known ...

Pediatrics

AI predicts blood clot risk in hospitalized children

An artificial intelligence (AI) tool developed at Vanderbilt University Medical Center accurately identified pediatric patients at high risk for blood clots in a clinical trial. However, there was no difference in outcomes ...

page 7 from 40